Keynote Speakers

Keynote Speakers:

Dr. Ali Khademhosseini is the Levi Knight Professor of Bioengineering, Chemical Engineering and Radiology at the Univeristy of California-Los Angeles (UCLA).  He is the Founding Director of the Center for Minimally Invasive Therapeutics at UCLA as well as an Associate Director of the California NanoSystems Insitute. He joined UCLA in Nov. 2017 from Harvard University where he was Professor of Medicine at Harvard Medical School (HMS) where he directed the Biomaterials Innovation Research Center (BIRC), a leading initiative in making engineered biomedical materials. He is recognized as a leader in combining micro- and nano-engineering approaches with advanced biomaterials for regenerative medicine applications.  In particular, his laboratory has pioneered numerous technologies and materials for controlling the architecture and function of engineered vascularized tissues. He has authored ~500 journal papers (H-index > 96, >34,500 citations) and 60 books/chapters.   In addition, he has delivered 300+ invited/keynote lectures.  Dr. Khademhosseini’s interdisciplinary research has been recognized by over 40 major national and international awards. He is a recipient of the Presidential Early Career Award for Scientists and Engineers, the highest honor given by the US government for early career investigators. In 2011, he received the Pioneers of Miniaturization Prize from the Royal Society of Chemistry (RSC) for his contribution to microscale tissue engineering and microfluidics.  In 2016, he received the Sr. Scientist Award of Tissue Engineering and Regenerative Medicine Society -Americas Chapter (TERMIS-AM) and in 2017 he received the Clemson Award of the Society for Biomaterials.  He is also a fellow of the American Institute of Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), Royal Society of Chemistry (RSC), Fellow of the Biomaterials Sciences and Engineering (FBSE) and American Association for the Advancement of Science (AAAS).  Currently he serves on the editorial board of numerous leading journals as well as an Associate Editor for ACS Nano (IF: 13.3) and a member of NIH BTSS study section.  He received his Ph.D. in bioengineering from MIT (2005), and MASc (2001) and BASc (1999) degrees from University of Toronto both in chemical engineering. Read more at:


Dr Nadim James Hallab is a Professor in the Dept of Orthopedics, Dept of Immunology, and Dept of Anatomy and Cell Biology at Rush University. He is a researcher of orthopedic implant biocompatibility and immunology, and teaches Biomaterials at the graduate level.  Dr Hallab’s research is focused on understanding (1) how implant debris is produced and what forms it takes and (2) how this debris is interacts with the innate and adaptive immune systems.  The long term goal of this lab is to improve implant performance by minimizing the biologic impact of implant debris. 

Primary Research Areas:

Dr Hallab research involves the study of implant degradation and quantifying and predicting biologic reactivity to soluble and particulate implant debris:

1) Immune reactivity to implant debris, from both an adaptive (T-cell) and innate (macrophage) perspective,

2) Implant connections (modular junctions) and implant fretting corrosion, metal release and metal-protein complex formation,

3) Peri-implant cell toxicity responses to implant degradation products such as metals,

4) Study of how material surfaces can be used to control immune and cell function such as bone deposition.